A safe, well-tolerated, and effective treatment for metastatic esophageal cancer

February 23, 2009

Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis.

More recently, chemotherapy has shown activity in metastatic ESCC. However, no generally accepted standard chemotherapy for advanced. In addition, more and more people pay close attention to the research of optimizing chemotherapy regimen.

Oxaliplatin is one kind of chemotherapeutic drug belonged to the third generation of platinum, which has played an important role in the treatment of colon and rectum cancer and other solid tumors. It has the synergistic effect with 5-FU with the slighter digestive tract reaction and hematotoxicity. Capecitabine which has the slighter side effect is the prosoma of 5-FU and can be taken orally and rapidly absorbed as an intact molecule in the gastrointestinal tract.

A research article to be published on February 21, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Dr. Qin, Professor Gu and Professor Zhao from Department of Medical Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, evaluated the efficacy toxic reaction and survival period of Oxaliplatin combined with capecitabine in treatment of patients with in patients with metastatic esophageal squamous cell cancer.

In their study, patients with metastatic metastatic ESCC were treated with oxaliplatin 120 mg/m2 intravenously on day 1 and capecitabine 1000 mg/m2 orally twice daily on days 1 to 14 in a 21-day treatment cycle as palliative chemotherapy. Each patient received at least two cycles. The efficacy, side effects and survival were evaluated then. Treatment was continued until unacceptable toxicity or disease progression.

Out of the 64 patients whose response could be evaluated, the partial response was 43.8%, Stable disease (SD) rate was 47.9% (26/ 64), and disease progression (PD) rate was 15.6% (10/ 64). The clinical benefit rate (PR + SD) was 84.4%. The median overall survival was 10.0 months (95% CI 8.3-11.7 months,respectively. It showed an improvement for quality of life after the chemotherapy

"Capecitabine was given orally twice daily on days 1 to 14 in a 21-day treatment cycle" Said Dr. Zhao. "It showed that this treatment can be given on outpatient basis, therefore the economic burden of the patients can be reduced."

The investigators believed that the oxaliplatin combined with capecitabine treatment provides a safe, well-tolerated, and effective treatment for patients with metastatic ESCC.

World Journal of Gastroenterology

---

---

	Treatment of Esophageal and Hypopharingeal Squamous Cell Carcinoma (Updates in Surgery) by Giovanni De Manzoni (Editor) Squamous cell carcinoma of the esophagus has a lower incidence than other gastrointestinal tract cancer; however, there are many difficult issued related to the choice of appropriate therapy for these patients. In recent years, the use of multimodal treatment has greatly improved the prognosis of patients affected by this disease but several aspects of the oncological and surgical management are still controversial. This book aims to give a homogeneous approach to esophageal cancer treatment, based on the author’s lifetime experience in conjunction with exhaustive review of recent literature. In each chapter surgeons and oncologists will find appropriate tools for correct management of the diagnosis and therapy of this difficult disease. The book analyzes all the aspects of staging and...
	21st Century Understanding Cancer Toolkit: Coping with Advanced Cancer - Metastatic Cancer, Caregiver Support, Palliative Care and Hospice, Advance Directives, End-of-Life Care, Pain Control, Grief by Progressive Management This massive guide, with over 600 pages and 23 chapters, has authoritative information and practical advice from the nation's cancer experts about advanced cancer, with valuable information for patients, families, and caregivers about every aspect of metastatic disease. Conveniently organized contents include: Coping With Advanced Cancer; When Cancer Returns; When Someone You Love Has Advanced Cancer: Support for Caregivers; Cancer Staging; Understanding Prognosis and Cancer Statistics; Metastatic Cancer: Questions and Answers; Home Care for Cancer Patients; Palliative Care in Cancer; Hospice; How To Find Resources in Your Own Community If You Have Cancer; Advance Directives; End-of-Life Care: Questions and Answers; Adjustment to Cancer: Anxiety and Distress; Cognitive Disorders and...
	Surviving Terminal Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About by Ben A. Williams (Author) Describes how to use the Internet and other sources to learn about experimental drug trials, effective forms of alternative medicine, and other breakthroughs with the potential for dramatically improving the odds of successful treatment.
	Methods of Cancer Diagnosis, Therapy and Prognosis: Gastrointestinal Cancer by M. A. Hayat (Editor) This third volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses diagnosis, therapy, and prognosis of Gastrointestinal Cancers. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included. This fully illustrated volume * Includes various aspects of esophageal cancer, gastric cancer, and pancreatic cancer * Highlights the methodologies used for diagnosis, therapy, and prognosis of these different cancers * Explains the molecular mechanisms underlying these cancers * Discusses the evaluation of FDG-PET/CT fusion imaging, endoscopic ultrasound and imaging, and the role of microRNA in prognosis * Details the classification of colon and gastric histological samples * Highlights treatments,...
	Care at the Close of Life: Evidence and Experience (Jama & Archives Journals) by Stephen McPhee (Author), Margaret A. Winker (Author), Michael W. Rabow (Author), Steven Z. Pantilat (Author), Amy J. Markowitz (Author) From one of the world’s leading medical journals comes the definitive evidence-based, full-color guide to end-of-life and palliative care "...represents an important milestone in the evolution of care for people with advanced disease—-for which its editors and authors and JAMA should be rightly proud. It is wonderful that JAMA had the foresight to publish a series on this topic, which, as medicine has become more technologically advanced and subspecialized, is often overlooked and, sometimes worse, avoided....this book will be invaluable for front-line clinicians, and indeed all health care practitioners—as care at the close of life is a part of almost all of medicine’s specialties and settings."--Irene J. Higginson, BMBS, PhD, FPPHM, FRCP; Dept. of Palliative Care,...
	Gastrointestinal Oncology (Cancer Treatment and Research) by A. B. Benson (Editor) Gastrointestinal tract malignancies encompass a spectrum of diseases with marked differences in etiology, incidence, biological behavior, and treatment outcome. The incidence of new gastrointestinal cases recorded yearly for patients residing in the United States is approximately 230,000, representing nearly 20% of all cancer cases. Worldwide, gastrointestinal malignancies are responsible for the largest number of cancer deaths, particularly because of the high incidence of hepatocellular and gastric cancer in other countries. Gastrointestinal Oncology is directed to those most involved in the multidisciplinary approach to the gastrointestinal cancer patient, including medical, radiation and surgical oncologists; gastroenterologists; interventional radiologists;...
	Carcinoma of the Esophagus (Contemporary Issues in Cancer Imaging) by Sheila C. Rankin (Editor) Esophageal cancer is a relatively uncommon but highly lethal malignancy. The incidence of adenocarcinoma is rapidly increasing and improved survival will depend on prevention, earlier diagnosis, improved staging and appropriate treatment. The multidisciplinary team approach toward patient care is critical in determining the management of patients with esophageal cancer. This volume provides a detailed review of new endoscopic methods of diagnosis, staging using both conventional and functional imaging and assessment of surgical and medical methods of therapy, providing all members of the team with a detailed overview of the diagnosis and management of this malignancy.
	Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions (Curbside Consultation in Gastroenterology) by Douglas Adler MD (Author) Are you looking for concise, practical answers to questions that are often left unanswered by traditional cancer references that are not designed for gastroenterologists? Are you seeking brief, evidence-based advice for complicated cases or patients with complications that need management? Curbside Consultation in GI Cancer for the Gastroenterologist: 49 Clinical Questions provides quick and direct answers to the thorny questions commonly posed during a “curbside consultation” between colleagues.Dr. Douglas G. Adler has designed this unique reference, which offers expert advice, preferences, and opinions on tough clinical questions commonly associated with GI cancer. The unique Q&A format provides quick access to current information related to GI cancer with the simplicity of a...
	Nutritional Management of Cancer Treatment Effects by Nagi B. Kumar (Author) Malnutrition and its related symptoms are both frequent and deleterious effects of cancer treatment. Despite the importance of targeted nutritional interventions in ameliorating these effects, however, publications providing up-to-date information on novel nutritional approaches and strategies are lacking. This book is intended to fill the void by describing and evaluating in detail the nutritional strategies that may be employed to alleviate a wide variety of cancer treatment effects. The guidance provided will help to improve the survival and quality of life of cancer patients, and has the potential to dramatically affect how evidence-based clinical practice is established and improved over the coming decade. The author is a distinguished expert in the field who has more than 25 years...
	Rapid Review Pathology Revised Reprint: With STUDENT CONSULT Online Access, 3e by Edward F. Goljan MD (Author) Get the most from your study time...and experience a realistic USMLE simulation! Rapid Review Pathology, by Edward F. Goljan, MD, makes it easy for you to master all of the pathology material covered on the USMLE Step 1 Exam. It combines an updated outline-format review of key concepts and hundreds of full-color images and margin notes - in print and online - PLUS more than 400 USMLE-style online questions! Rated A+ in First Aid for the USMLE Step 1 2012!Access all the information you need to know quickly and easily with a user-friendly, two-color outline format that includes High-Yield Margin Notes and Key Points. Practice with our testing platform on USMLE Consult for a realistic testing experience that fully prepares you for the exam. Tailor your exam by category, subcategory, or...